<!doctype html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link
    crossorigin="anonymous"
    href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css"
    integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w=="
    referrerpolicy="no-referrer"
    rel="stylesheet"
  />
  <link rel="stylesheet" href="./static/css/oxford.css">
  <link rel="stylesheet" href="./static/css/outliers.css">

  <title>Static outliers for NHS South West London CCG</title>
</head>
<body>
    <div class="bg-dark">
      <div class="container d-flex justify-content-center">
        <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
      </div>
    </div>

    <header>
      <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
        <div class="container">
          <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
        </div>
      </nav>
    </header>

    <main id="content">
      <div class="bg-oxford-50 mb-4">
        <div class="container pt-5 pb-4">
          <div class="row">
            <div class="col-12">
              <h1 class="display-5 fw-bold lh-1">Static outliers for NHS South West London CCG</h1>
            </div>
            <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
              <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
                explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                prescribers and organisations to audit and review prescribing.</p>
              <div class="collapse" id="explainerTextCollapse">
                <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
                    in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between June 2021 and December 2021. We then calculate the
                    mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
                    population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
                </p>
                <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
                    it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
                </p>
                <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=ccg+36L">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
                    send short or detailed feedback.
                </p>
              </div>
              <p>
                <button id="explainerTextBtn" class="btn btn-link p-0" type="button" data-bs-toggle="collapse" data-bs-target="#explainerTextCollapse" aria-expanded="false" aria-controls="explainerTextCollapse">
                  Show more &plus;
                </button>
              </p>
            </div>
          </div>
        </div>
      </div>
    </main>

    <section aria-labelledby="higherHeading">
      <div class="container">
        <h2 class="pb-3" id="higherHeading">Prescribing where NHS South West London CCG is higher than most</h2>
        <button id="higherHeading-lowShowHide" class="btn btn-outline-danger-outline mb-3" type="button">Hide low numbers</button>
      </div>
      <div class="container mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="low_number row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020W0&amp;denomIds=4.7.2&amp;selectedTab=summary">Morphine (Opium Tincture)</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>4</td>
      <td>Opioid analgesics</td>
      <td>146719</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_NFpb2iYEsUEcFL0NggCrSlsFakVNrC"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_NFpb2iYEsUEcFL0NggCrSlsFakVNrC" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020W0AAAAAA&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine (Opium tincture) 10mg/ml oral drops sugar free : 4</a></li></ul></td></tr><tr class="low_number row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0504010K0&amp;denomIds=5.4.1&amp;selectedTab=summary">Primaquine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Antimalarials</td>
      <td>34799</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_gTS2zRH5A2Kxk5qmSiU1uoJQMLJWQeH4"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_gTS2zRH5A2Kxk5qmSiU1uoJQMLJWQeH4" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0504010K0AAAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Primaquine 7.5mg tablets : 1</a></li></ul></td></tr><tr class="low_number row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=090603100&amp;denomIds=9.6.3&amp;selectedTab=summary">Other vitamin C (Ascorbic acid) preparations</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Vitamin C (ascorbic acid)</td>
      <td>1557</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_8ccZdYoo7I4DiiMpjqgLQpGhNCNnh6AR"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_8ccZdYoo7I4DiiMpjqgLQpGhNCNnh6AR" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=090603100BBCVA0&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Solgar Vitamin C 1000mg capsules : 1</a></li></ul></td></tr><tr class="low_number row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0901011X0&amp;denomIds=9.1.1&amp;selectedTab=summary">Ferrous calcium citrate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Oral iron</td>
      <td>108917</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_0Iht1I61PxDdKRtsI1FjahflVMxWqoy"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_0Iht1I61PxDdKRtsI1FjahflVMxWqoy" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0901011X0AAAAAA&amp;denomIds=9.1.1&amp;selectedTab=summary" target="_blank">Ferrous calcium citrate 181.5mg tablets : 1</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0901030P0&amp;denomIds=9.1.3&amp;selectedTab=summary">Desferrioxamine mesilate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>6</td>
      <td>Hypoplastic/haemolytic and renal anaemias</td>
      <td>73</td>
      <td>0.08</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>9.74</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_VA1sc3ij7ap1ExpKSZe0MoJtMaa0gNS"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_VA1sc3ij7ap1ExpKSZe0MoJtMaa0gNS" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0901030P0BBAAAA&amp;denomIds=9.1.3&amp;selectedTab=summary" target="_blank">Desferal 500mg powder for solution for injection vials : 6</a></li></ul></td></tr><tr class="row_6">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020H0&amp;denomIds=1.4.2&amp;selectedTab=summary">Co-phenotrope (Diphenox hydrochloride/atropine sulfate)</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_5_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>165</td>
      <td>Antimotility drugs</td>
      <td>14114</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>8.49</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_ECTVKKZIItBqguESYmC9EcFwKRLLtBAh"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_ECTVKKZIItBqguESYmC9EcFwKRLLtBAh" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_5_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020H0AAAAAA&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Co-phenotrope 2.5mg/0.025mg tablets : 162</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020H0BBAEAA&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Lomotil 2.5mg/25microgram tablets (Imported) : 3</a></li></ul></td></tr><tr class="row_7">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=130400000&amp;denomIds=13.4&amp;selectedTab=summary">Other topical corticosteroid preparations</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_6_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>82</td>
      <td>Topical corticosteroids</td>
      <td>140315</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>8.32</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_pEKwSKQRSg4EbYnRUElRVonhwTISlGD0"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_pEKwSKQRSg4EbYnRUElRVonhwTISlGD0" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_6_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=130400000AABLBL&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Propylene glycol 40% in Clobetasol 0.05% cream : 82</a></li></ul></td></tr><tr class="low_number row_8">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503010AK&amp;denomIds=5.3.1&amp;selectedTab=summary">Darunavir/cobicistat</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_7_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>HIV infection</td>
      <td>97</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>8.04</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_FCrGQGxIMFqa0AjKTjQhixijklQqxjSQ"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_FCrGQGxIMFqa0AjKTjQhixijklQqxjSQ" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_7_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503010AKBBAAAA&amp;denomIds=5.3.1&amp;selectedTab=summary" target="_blank">Rezolsta 800mg/150mg tablets : 1</a></li></ul></td></tr><tr class="row_9">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0403040R0&amp;denomIds=4.3.4&amp;selectedTab=summary">Oxitriptan</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_8_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>11</td>
      <td>Other antidepressant drugs</td>
      <td>203319</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>6.09</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_mPJDbO1Kf0zpSN0WGcCZEhspjCLChNrS"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_mPJDbO1Kf0zpSN0WGcCZEhspjCLChNrS" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_8_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0403040R0BEAAAK&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">HealthAid 5-HTP HydroxyTryptoPhan 50mg tablets : 11</a></li></ul></td></tr><tr class="row_10">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000X0&amp;denomIds=14.4&amp;selectedTab=summary">Meningococcal A + C + W135 + Y vaccine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_9_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>116</td>
      <td>Vaccines and antisera</td>
      <td>183961</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>5.82</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_5oAU1eEhhYlgq0EMWmgpAUQIDwHRYFNg"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_5oAU1eEhhYlgq0EMWmgpAUQIDwHRYFNg" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_high_9_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000X0BJAAAG&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Nimenrix vacc inj 0.5ml pre-filled syringes : 116</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <section aria-labelledby="lowerHeading">
      <div class="container">
        <h2 class="pb-3" id="lowerHeading">Prescribing where NHS South West London CCG is lower than most</h2>
        <button id="lowerHeading-lowShowHide" class="btn btn-outline-danger-outline mb-3" type="button">Hide low numbers</button>
      </div>
      <div class="container mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0&amp;denomIds=9.6.3&amp;selectedTab=summary">Ascorbic acid</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1556</td>
      <td>Vitamin C (ascorbic acid)</td>
      <td>1557</td>
      <td>1.00</td>
      <td>1.00</td>
      <td>0.00</td>
      <td>-10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_uoi6CJI4YGUXRhYRHmhUgZWRCaiSOV"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_uoi6CJI4YGUXRhYRHmhUgZWRCaiSOV" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0AAAFAF&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Ascorbic acid 50mg tablets : 357</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0AAAGAG&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Ascorbic acid 100mg tablets : 447</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0AAAHAH&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Ascorbic acid 200mg tablets : 329</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0AAAIAI&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Ascorbic acid 500mg tablets : 393</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0AABGBG&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Ascorbic acid 500mg/5ml oral liquid : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0AABIBI&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Ascorbic acid 500mg capsules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0AABJBJ&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Ascorbic acid 500mg modified-release tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0AACACA&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Ascorbic acid powder : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0CBAABJ&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Lamberts Vitamin C Time Release 500mg tablets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0CBABBX&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Lamberts Vitamin C Time Release 1000mg tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906031C0CGADAI&amp;denomIds=9.6.3&amp;selectedTab=summary" target="_blank">Ascorb 500mg tablets : 10</a></li></ul></td></tr><tr class="row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0&amp;denomIds=1.4.2&amp;selectedTab=summary">Loperamide hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>13932</td>
      <td>Antimotility drugs</td>
      <td>14114</td>
      <td>0.99</td>
      <td>1.00</td>
      <td>0.00</td>
      <td>-5.29</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_YuofZv4q8QN1FiVRKy2gDaKf6jBSxxs"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_YuofZv4q8QN1FiVRKy2gDaKf6jBSxxs" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0AAAAAA&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Loperamide 2mg capsules : 11275</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0AAABAB&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Loperamide 1mg/5ml oral solution sugar free : 706</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0AAADAD&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Loperamide 2mg tablets : 1474</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0AAAPAP&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Loperamide 25mg/5ml oral suspension : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0AAAQAQ&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Loperamide 25mg/5ml oral solution : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0AAARAR&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Loperamide 2mg orodispersible tablets sugar free : 138</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0BBAAAA&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Imodium Original 2mg capsules : 48</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0BBABAB&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Imodium 1mg/5ml oral solution : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0BBAHAA&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Imodium Classic 2mg capsules : 147</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0BBAKAR&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Imodium Instant Melts 2mg orodispersible tablets : 60</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0BBAMAR&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Imodium Instants 2mg orodispersible tablets : 19</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0104020L0BIAAAD&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Norimode 2mg tablets : 13</a></li></ul></td></tr><tr class="row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0&amp;denomIds=4.8.1&amp;selectedTab=summary">Gabapentin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>47111</td>
      <td>Control of epilepsy</td>
      <td>340371</td>
      <td>0.14</td>
      <td>0.25</td>
      <td>0.04</td>
      <td>-2.54</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_mhORcokmLIowCAYJKIRFLTwRgwJBNomI"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_mhORcokmLIowCAYJKIRFLTwRgwJBNomI" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0AAAAAA&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 100mg capsules : 12560</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0AAABAB&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 300mg capsules : 27403</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0AAACAC&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 400mg capsules : 2169</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0AAAJAJ&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 600mg tablets : 4365</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0AAAKAK&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 800mg tablets : 154</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0AAAPAP&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 300mg/5ml oral liquid : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0AABGBG&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 50mg/ml oral solution sugar free : 395</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0BBAAAA&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Neurontin 100mg capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0BBABAB&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Neurontin 300mg capsules : 47</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0408010G0BBACAC&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Neurontin 400mg capsules : 7</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0703021Q0&amp;denomIds=7.3.2&amp;selectedTab=summary">Desogestrel</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>31748</td>
      <td>Oral progestogen-only contraceptives</td>
      <td>35202</td>
      <td>0.90</td>
      <td>0.94</td>
      <td>0.02</td>
      <td>-2.43</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_BgdwgylUxIV9cAYcQCVHELUcFARGxZFN"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_BgdwgylUxIV9cAYcQCVHELUcFARGxZFN" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0703021Q0AAAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Desogestrel 75microgram tablets : 24741</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0703021Q0BBAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Cerazette 75microgram tablets : 1902</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0703021Q0BDAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Cerelle 75microgram tablets : 4931</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0703021Q0BFAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Desorex 75microgram tablets : 41</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0703021Q0BGAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Desomono 75microgram tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0703021Q0BHAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Zelleta 75microgram tablets : 68</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0703021Q0BIAAAA&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Feanolla 75microgram tablets : 64</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0&amp;denomIds=5.3.2&amp;selectedTab=summary">Aciclovir</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>13965</td>
      <td>Herpes simplex and varicella-zoster</td>
      <td>15504</td>
      <td>0.90</td>
      <td>0.95</td>
      <td>0.02</td>
      <td>-2.34</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_lMOMYonOuIsgAu4jKLgVIMgiMiqioMEg"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_lMOMYonOuIsgAu4jKLgVIMgiMiqioMEg" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0AAAAAA&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg/5ml oral suspension sugar free : 62</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0AAABAB&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg tablets : 3385</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0AAACAC&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg tablets : 7275</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0AAADAD&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg tablets : 2616</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0AAAEAE&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg dispersible tablets : 118</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0AAAFAF&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg/5ml oral suspension sugar free : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0AAAGAG&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg dispersible tablets : 394</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0AAAHAH&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg dispersible tablets : 96</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0BBABAA&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Zovirax 200mg/5ml oral suspension : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0503021C0BBAGAG&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Zovirax 200mg dispersible tablets : 2</a></li></ul></td></tr><tr class="row_6">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0&amp;denomIds=14.4&amp;selectedTab=summary">Influenza</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_5_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>173987</td>
      <td>Vaccines and antisera</td>
      <td>183961</td>
      <td>0.95</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-2.23</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_J4TWKsDDQxv15DhECowSFc4DUdGz8SGW"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_J4TWKsDDQxv15DhECowSFc4DUdGz8SGW" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_5_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0AAAFAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Influenza vaccine (surface antigen, inact) inj 0.5ml pfs : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0AAAKAK&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Influenza vaccine (split virion, inactivated) inj 0.5ml pfs : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0AAAMAM&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Adjuvanted trivalent flu vacc (SA, inact) inj 0.5ml pfs : 2906</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0AAANAN&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Adjuvanted quadrivalent flu vacc (SA, inact) inj 0.5ml pfs : 40</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0BCADAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Influvac sub-unit Tetra vacc inj 0.5ml pre-filled syringes : 16716</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0BWAAAK&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Quadrivalent Flu/Vac/Split inj 0.5ml pfs : 16761</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0BXAAAM&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Fluad vacc inj 0.5ml pre-filled syringes : 31452</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0BYAAAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Influenza Tetra MYL vacc inj 0.5ml pre-filled syringes : 932</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0BZAAAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Flucelvax Tetra vacc inj 0.5ml pre-filled syringes : 49517</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0CCAAAN&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Fluad Tetra vaccine inj 0.5ml pre-filled syringes : 53659</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=1404000H0CEAAAP&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Supemtek Quadrivalent vaccine (recombinant) inj 0.5ml pfs : 1992</a></li></ul></td></tr><tr class="row_7">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0&amp;denomIds=9.6.4&amp;selectedTab=summary">Colecalciferol</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_6_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>354650</td>
      <td>Vitamin D</td>
      <td>373540</td>
      <td>0.95</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-2.11</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_RUPiUkZxg1EQyIioqChuFMbBiOaQGFQE"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_RUPiUkZxg1EQyIioqChuFMbBiOaQGFQE" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_6_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAACAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,000unit tablets : 164</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAANAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit capsules : 19561</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAAUAU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 15,000units/5ml oral suspension : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABABA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit capsules : 28</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABFBF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 600unit capsules : 70</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit tablets : 23549</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABHBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit capsules : 4920</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABIBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit capsules : 1504</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABNBN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000units/5ml oral solution : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABSBS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g tablets : 1863</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABTBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000units/ml oral drops sugar free : 300</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABUBU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 1.25g chew tab : 2878</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABWBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 26735</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABXBX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 440unit/Calcium carb 1.25g efferv gran sach : 515</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABYBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 64141</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AABZBZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit/Calcium phosphate 3.1g oral pdr sach : 308</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACBCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g efferv tab : 3863</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACCCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACDCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 750mg tablets : 6733</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACHCH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 300,000units/1ml inj ampoules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACICI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/dose oral spray sugar free : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACNCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit tablets : 77</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACPCP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,200unit tablets : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACQCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit tablets : 49</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACRCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit tablets : 880</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACSCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit tablets : 11119</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACUCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/5ml oral solution : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACVCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 40,000unit capsules : 744</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AACYCY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit tablets : 18</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADADA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops sugar free : 55</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADBDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit tablets : 1274</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADDDD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit orodispersible tablets sugar free : 19</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADFDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,200unit capsules : 220</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADHDH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000units/1ml soln ud amp sugar free : 24</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADIDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 880unit / Calcium carbonate 2.5g chew tab : 966</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADKDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit tablets : 73</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADLDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit / Calcium carbonate 2.5g chewable tab : 240</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADNDN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral drops sugar free : 120</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADPDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral solution sugar free : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADQDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,400units/ml oral drops sugar free : 24</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADRDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit capsules : 3679</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADSDS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 15,000units/5ml oral solution : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADTDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,740units/ml oral drops sugar free : 88</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADUDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000units/1ml soln ud amp sugar free : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADVDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit capsules : 210</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADWDW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,200unit capsules : 90</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADXDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,500unit capsules : 82</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADYDY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AADZDZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 30,000unit capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAEAEA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit capsules : 58</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAEBEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit / Calcium carbonate 2.5g chew tab : 365</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAECEC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit capsules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAEEEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit tablets : 352</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAEJEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,600unit capsules : 143</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAEKEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit capsules : 56</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAELEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit tablets : 1968</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAENEN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 15,000units/5ml oral solution sugar free : 18</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAEQEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit capsules : 154</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAERER&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit chewable tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAETET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/ml oral drops sugar free : 93</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0AAFGFG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops : 532</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BEAADW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 2,200unit capsules : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BEACBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 1,000unit tablets : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BEADBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 1,000unit capsules : 54</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BEAEBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 400unit capsules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BHAABN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">BabyD 1,000units/ml oral solution : 123</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIAABI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 400unit capsules : 64</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 1,000unit capsules : 243</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIACDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,500unit capsules : 22</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIADDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 10,000unit capsules : 27</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIAEDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 20,000unit capsules : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIAFDZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 30,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIAGBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid drops : 28</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIAICU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid : 49</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIAJAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 800unit capsules : 39</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIAMDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 20,000unit Vegan capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BIANBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml Vegan liquid drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BJABEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Lamberts Vitamin D3 400unit tablets : 274</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BKAABS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 tablets : 15907</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BKABDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 One a Day 1000mg/880unit chewable tablets : 1149</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BMAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit tablets : 10724</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BMABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit capsules : 140</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BNAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 chewable tablets tutti frutti : 31455</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BNABBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Lemon chewable tablets : 6028</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BNACCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 2122</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BNADCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 750mg/200unit caplets : 20690</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BPAABX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Cacit D3 effervescent granules sachets : 220</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BQAABW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calceos 500mg/400unit chewable tablets : 1664</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BRAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 chewable tablets : 3462</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BRABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 Forte chewable tablets : 12269</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BRADDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 1000mg/800unit Once Daily chewable tablets : 165</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BSAABZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calfovit D3 oral powder sachets : 125</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BUAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Natecal D3 600mg/400unit chewable tablets : 137</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit tablets : 202</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWABCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWACCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit tablets : 94</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAEDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000unit tablets : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAFCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 5,000unit tablets : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAGAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,000unit tablets : 48</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAHEP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000units/ml oral solution : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAIBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000units/ml oral drops : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAJEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAKCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit tablets : 115</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWALBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAMDW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,200unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWANDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,200unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAPDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit capsules : 66</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWASEN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,000units/ml oral solution : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAUAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit capsules : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAVDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,500unit capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAWDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 25,000unit tablets : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWAXCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 40,000unit capsules : 64</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWBABH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit capsules : 35</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BWBBDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit capsules : 55</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BXAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 800unit capsules : 4824</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BXABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 3,200unit capsules : 237</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BXACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 20,000unit capsules : 333</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BXADDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 2,740units/ml oral drops : 67</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0BZAACI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">DLux 400 oral spray : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CCAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 forte 3,000units/ml liquid : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CEAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 800unit capsules : 1288</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CEABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 1,000unit capsules : 79</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CEACEA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 5,000unit capsules : 59</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CEADDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 20,000unit capsules : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CGAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 20,000unit capsules : 2084</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CHAAEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 400unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CHABBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 1,000unit tablets : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CHADAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000unit tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CHAECN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 5,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CHAFCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 10,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CHAGCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 20,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CHAKCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 2,000units/ml liquid : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CJAACS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 800unit tablets : 11476</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CJABEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 4,000unit tablets : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CNACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Plenachol D3 20,000unit capsules : 1041</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CNADCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Plenachol D3 40,000unit capsules : 384</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CVAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 20,000unit capsules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CVABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 1,000unit capsules : 24</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CWAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Evacal D3 1500mg/400unit chewable tablets : 12735</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0CYAADA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">HealthAid Vitamin D3 200units/drop oral drops : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DBAACN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 High Strength 5,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DCABDD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 Lemon Melts 2,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DDAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Kora LiquiD 3000units/ml oral solution : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DFAADH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000units/1ml oral solution : 233</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DFABDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 2,400units/ml oral drops : 49</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DFACDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000units/1ml oral solution : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DFADAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 800unit capsules : 92</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DFAEBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 400unit capsules : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DFAFEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000unit capsules : 32</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DFAGEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000unit capsules : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DFAHEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 5,600unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DGAADI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">TheiCal-D3 1000mg/880unit chewable tablets : 11039</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DHAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 1,000unit tablets : 14608</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DHABDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 25,000unit tablets : 1127</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DIAADN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 10,000units/ml oral drops : 219</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DIABDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 25,000units/2.5ml oral solution : 126</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DKAFET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 400units/ml for infants and children dps : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DMAAEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calci-D 1000mg/1,000unit chewable tablets : 1694</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DNAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 800unit capsules : 218</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DNABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 3,200unit capsules : 39</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DNACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 20,000unit capsules : 1117</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DPAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 800unit capsules : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DPABCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 800unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DPAEEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 4,000unit tablets : 28</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DPAGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 1,000unit tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DPAJEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 400unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DZAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 200unit with Calcium 500mg chewable tablets : 27</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DZABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit with Calcium 500mg chewable tablets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DZACBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit with Calcium 600mg chew tab tutti frutti : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0DZADBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit with Calcium 600mg chewable tablets lemon : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0ECAIDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 2,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0ECAJCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 5,000unit tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0ECAKCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 20,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0ECAMDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 20,000unit capsules : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0ECANEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 25,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0906040G0ECAPEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 50,000unit capsules : 3</a></li></ul></td></tr><tr class="row_8">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0206040AE&amp;denomIds=2.6.4&amp;selectedTab=summary">Naftidrofuryl oxalate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_7_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>390</td>
      <td>Peripheral vasodilators and related drugs</td>
      <td>914</td>
      <td>0.43</td>
      <td>0.70</td>
      <td>0.14</td>
      <td>-1.98</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_4FWe44653ha1J5ePMW2ShUUEamdKBgu"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_4FWe44653ha1J5ePMW2ShUUEamdKBgu" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_7_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0206040AEAAAAAA&amp;denomIds=2.6.4&amp;selectedTab=summary" target="_blank">Naftidrofuryl 100mg capsules : 343</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0206040AEBBAAAA&amp;denomIds=2.6.4&amp;selectedTab=summary" target="_blank">Praxilene 100mg capsules : 47</a></li></ul></td></tr><tr class="row_9">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0704050Z0&amp;denomIds=7.4.5&amp;selectedTab=summary">Sildenafil (Erectile Dysfunction)</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_8_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>34484</td>
      <td>Drugs for erectile dysfunction</td>
      <td>49109</td>
      <td>0.70</td>
      <td>0.77</td>
      <td>0.03</td>
      <td>-1.96</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_KrAil2ZBowsICiKCyE1UXFrEZQVckWsI"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_KrAil2ZBowsICiKCyE1UXFrEZQVckWsI" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_8_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0704050Z0AAAAAA&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Sildenafil 50mg tablets : 12816</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0704050Z0AAABAB&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Sildenafil 25mg tablets : 2221</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0704050Z0AAACAC&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Sildenafil 100mg tablets : 19293</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0704050Z0AAAKAK&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Sildenafil 10mg/5ml oral suspension : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0704050Z0BBAAAA&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Viagra 50mg tablets : 22</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0704050Z0BBACAC&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Viagra 100mg tablets : 131</a></li></ul></td></tr><tr class="row_10">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0&amp;denomIds=4.7.2&amp;selectedTab=summary">Morphine sulfate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_9_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>22032</td>
      <td>Opioid analgesics</td>
      <td>146719</td>
      <td>0.15</td>
      <td>0.22</td>
      <td>0.04</td>
      <td>-1.94</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_VMYF20MA6IeR0FFHQVBVC7gAuICLoBL"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_VMYF20MA6IeR0FFHQVBVC7gAuICLoBL" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_9_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAA4A4&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 1mg/1ml solution for injection ampoules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAA6A6&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 20mg/ml oral solution sugar free : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/1ml solution for injection ampoules : 1148</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAACAC&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 15mg/1ml solution for injection ampoules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAADAD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 30mg/1ml solution for injection ampoules : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAAFAF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 20mg/1ml solution for injection ampoules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAAHAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 100mg modified-release tablets : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAAIAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release tablets : 164</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAAKAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release tablets : 2080</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAALAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release tablets : 932</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAAMAM&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 60mg/2ml solution for injection ampoules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AACDCD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg tablets : 453</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AACECE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 20mg tablets : 209</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AACFCF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 15mg modified-release tablets : 735</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AACGCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 5mg modified-release tablets : 1081</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AACNCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/5ml oral solution : 6664</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AACPCP&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release granules sachets sugar free : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AACVCV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 20mg modified-release granules sachets sugar free : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AADCDC&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release granules sachets sugar free : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AADRDR&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 50mg tablets : 36</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AADUDU&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 90mg modified-release capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AADWDW&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 150mg modified-release capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAEBEB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 100mg modified-release capsules : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAEFEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release capsules : 878</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAEGEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release capsules : 562</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAEHEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release capsules : 168</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAEIEI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 200mg modified-release capsules : 34</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAFZFZ&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 5mg/5ml solution for injection ampoules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0AAGAGA&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/10ml solution for injection ampoules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BBAAAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 10mg tablets : 472</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BBABAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 30mg tablets : 162</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BBACAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 60mg tablets : 69</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BBADAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 100mg tablets : 58</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BBAEAG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 200mg tablets : 39</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BBAFCV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus suspension 20mg granules sachets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BBAGCP&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus suspension 30mg granules sachets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BBAKCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 5mg tablets : 118</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BBALCF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 15mg tablets : 211</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BCABA6&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Oramorph 20mg/ml concentrated oral solution : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BCAGCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Oramorph 10mg/5ml oral solution : 4578</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BHACCD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 10mg tablets : 231</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BHADCE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 20mg tablets : 56</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BHAFDR&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 50mg tablets : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BIAAEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 30mg capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BIABEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 60mg capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BIACDU&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 90mg capsules : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BIADDV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 120mg capsules : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BKAAEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 10mg modified-release capsules : 320</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BKABEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 30mg modified-release capsules : 204</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BKACEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 60mg modified-release capsules : 87</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BKADEB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 100mg modified-release capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BKAEEI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 200mg modified-release capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BNAAAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 10mg tablets : 37</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=36L&amp;numIds=0407020Q0BNABAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 30mg tablets : 32</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <script
      crossorigin="anonymous"
      integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg=="
      referrerpolicy="no-referrer"
      src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"
    ></script>
    <script>
      var tooltipTriggerList = [].slice.call(
        document.querySelectorAll('[data-bs-toggle="tooltip"]')
      );
      var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
        return new bootstrap.Tooltip(tooltipTriggerEl);
      });
    </script>

    <script>
      ["higherHeading-lowShowHide", "lowerHeading-lowShowHide"].forEach(function (
        btn
      ) {
        var toggleButton = document.getElementById(btn);
        var section = toggleButton.closest("section");
        toggleButton.addEventListener("click", function (e) {
          var lowRows = section.querySelectorAll("tr.low_number");
          lowRows.forEach(function (row) {
            return row.classList.toggle("d-none");
          });

          if (toggleButton.textContent === "Hide low numbers") {
            toggleButton.textContent = "Show low numbers";
            toggleButton.classList.remove("btn-outline-danger");
            toggleButton.classList.add("btn-outline-success");
          } else {
            toggleButton.textContent = "Hide low numbers";
            toggleButton.classList.remove("btn-outline-success");
            toggleButton.classList.add("btn-outline-danger");
          }
        });
      });
    </script>

    <script>
      var explainerTextCollapse = document.getElementById("explainerTextCollapse");
      var explainerTextBtn = document.getElementById("explainerTextBtn");
      explainerTextCollapse.addEventListener("hidden.bs.collapse", function () {
        explainerTextBtn.textContent = "Show more +";
      });
      explainerTextCollapse.addEventListener("shown.bs.collapse", function () {
        explainerTextBtn.textContent = "Show less -";
      });
    </script>
</body>

</html>